These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19706598)

  • 1. Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.
    Sin WC; Tse M; Planque N; Perbal B; Lampe PD; Naus CC
    J Biol Chem; 2009 Oct; 284(43):29935-44. PubMed ID: 19706598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
    Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
    J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More insights into the CCN3/Connexin43 interaction complex and its role for signaling.
    Gellhaus A; Wotzlaw C; Otto T; Fandrey J; Winterhager E
    J Cell Biochem; 2010 May; 110(1):129-40. PubMed ID: 20336664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.
    Sin WC; Bechberger JF; Rushlow WJ; Naus CC
    J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells.
    Gellhaus A; Dong X; Propson S; Maass K; Klein-Hitpass L; Kibschull M; Traub O; Willecke K; Perbal B; Lye SJ; Winterhager E
    J Biol Chem; 2004 Aug; 279(35):36931-42. PubMed ID: 15181016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
    Vallacchi V; Daniotti M; Ratti F; Di Stasi D; Deho P; De Filippo A; Tragni G; Balsari A; Carbone A; Rivoltini L; Parmiani G; Lazar N; Perbal B; Rodolfo M
    Cancer Res; 2008 Feb; 68(3):715-23. PubMed ID: 18245471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cx43 increases serum induced filopodia formation via activation of p21-activated protein kinase 1.
    Kameritsch P; Kiemer F; Beck H; Pohl U; Pogoda K
    Biochim Biophys Acta; 2015 Nov; 1853(11 Pt A):2907-17. PubMed ID: 26255026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
    Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
    J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carboxy-terminal tail of connexin43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells.
    Crespin S; Bechberger J; Mesnil M; Naus CC; Sin WC
    J Cell Biochem; 2010 Jun; 110(3):589-97. PubMed ID: 20512920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of Rac1 GTPase reveals its critical role in actin stress fiber formation and focal adhesion complex assembly.
    Guo F; Debidda M; Yang L; Williams DA; Zheng Y
    J Biol Chem; 2006 Jul; 281(27):18652-9. PubMed ID: 16698790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The connexin 43/ZO-1 complex regulates cerebral endothelial F-actin architecture and migration.
    Chen CH; Mayo JN; Gourdie RG; Johnstone SR; Isakson BE; Bearden SE
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C600-7. PubMed ID: 26289751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
    Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M
    Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
    Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
    Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of beta2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix components.
    Menna PL; Peche LY; Alonso DF; Gomez DE
    Int J Mol Med; 2005 Jan; 15(1):91-5. PubMed ID: 15583833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
    Chen PC; Cheng HC; Tang CH
    Carcinogenesis; 2013 Jul; 34(7):1669-79. PubMed ID: 23536580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RFX1-mediated CCN3 induction that may support chondrocyte survival under starved conditions.
    Mizukawa T; Nishida T; Akashi S; Kawata K; Kikuchi S; Kawaki H; Takigawa M; Kamioka H; Kubota S
    J Cell Physiol; 2021 Oct; 236(10):6884-6896. PubMed ID: 33655492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
    Böhlig L; Metzger R; Rother K; Till H; Engeland K
    Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer.
    Dokmanovic M; Hirsch DS; Shen Y; Wu WJ
    Mol Cancer Ther; 2009 Jun; 8(6):1557-69. PubMed ID: 19509242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.